Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Indivior Pharmaceuticals Inc. (INDV) had Revenue of $343.00M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$343.00M
Net Income	$122.00M
Cost of Goods Sold	$50.00M
Gross Profit	$293.00M
Operating Expenses	$184.00M
Operating Income	$159.00M
Non-Operating Income/Expense	$1.00M
Pre-Tax Income	$160.00M
Normalized Pre-Tax Income	$160.00M
Income after Taxes	$122.00M
Income from Continuous Operations	$122.00M
Consolidated Net Income/Loss	$122.00M
Normalized Income after Taxes	$122.00M
EBIT	$159.00M
EBITDA	$162.00M
Weighted-Average Shares Outstanding (Basic)	119.00M
Weighted-Average Shares Outstanding (Diluted)	124.00M
Earnings per Share (EPS) (Basic)	$1.02
Earnings per Share (EPS) (Diluted)	$0.98
Balance Sheet Financials
Current Assets	$725.00M
Property, Plant, and Equipment	$162.00M
Long-Term Assets	$507.00M
Total Assets	$1.23B
Current Liabilities	$868.00M
Long-Term Debt	$487.00M
Long-Term Liabilities	$573.00M
Total Liabilities	$1.44B
Common Equity	$-207.00M
Tangible Shareholders Equity	$-210.00M
Shareholders Equity	$-208.00M
Common Shares Outstanding	118.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$220.00M
Cash Flow from Investing Activities	$-27.00M
Cash Flow from Financial Activities	$-166.00M
Beginning Cash	$195.00M
End Cash	$222.00M
Increase/Decrease in Cash	$27.00M
Stock-Based Compensation	$20.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.84
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.75
Debt to Equity Ratio	-2.34
Gross Margin	85.71%
Operating Margin	46.36%
EBIT Margin	46.36%
EBITDA Margin	--
Pre-Tax Profit Margin	46.65%
Profit Margin	35.57%
Free Cash Flow	$193.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.28
Inventory Turnover	0.33
Receiveable Turnover	1.20
Days Sales in Receivables	75.31
Return on Equity	-58.94%
Return on Tangible Equity	-58.10%
Return on Assets	9.89%
Return on Investments	43.73%
Book Value Per Share	$-1.76
Free Cash Flow per Share	$1.56
Operating Cash Flow per Share	$1.77

Data from Zacks Investment Research, Inc.